CASTLE BIOSCIENCES INC Quarterly Operating Margin in % from Q4 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Castle Biosciences Inc quarterly/annual Operating Margin history and growth rate from Q4 2019 to Q3 2024.
  • Castle Biosciences Inc Operating Margin for the quarter ending September 30, 2024 was -0.33 %, a 99.3% increase year-over-year.
  • Castle Biosciences Inc annual Operating Margin for 2023 was -30.9 %, a 41.8% increase from 2022.
  • Castle Biosciences Inc annual Operating Margin for 2022 was -53.2 %, a 24.8% decline from 2021.
  • Castle Biosciences Inc annual Operating Margin for 2021 was -42.6 %, a 308% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -0.33 +44 +99.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -5.48 +52.5 +90.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -16.7 +35.7 +68.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -30.9 +22.2 +41.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -44.4 +8.34 +15.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -57.9 -7.59 -15.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -52.5 +9 +14.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -53.2 -10.6 -24.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -52.7 -20.3 -62.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -50.3 -24.7 -96.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -61.5 -44 -253% Jan 1, 2022 Mar 31, 2022
Q4 2021 -42.6 -32.2 -308% Oct 1, 2021 Dec 31, 2021
Q3 2021 -32.4 -30.9 -2172% Jul 1, 2021 Sep 30, 2021
Q2 2021 -25.7 -37.5 -316% Apr 1, 2021 Jun 30, 2021
Q1 2021 -17.4 -31.8 -222% Jan 1, 2021 Mar 31, 2021
Q4 2020 -10.4 -24.6 -174% Oct 1, 2020 Dec 31, 2020
Q3 2020 -1.42 Jul 1, 2020 Sep 30, 2020
Q2 2020 11.9 Apr 1, 2020 Jun 30, 2020
Q1 2020 14.3 Jan 1, 2020 Mar 31, 2020
Q4 2019 14.1 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.